New tezepelumab data shows improvements for severe asthma subgroup
TSLP blocker reduced exacerbations in patients with severe asthma and comorbid nasal polyps
Read More
Tag: nasal polyps
FDA set to review GSK’s Nucala for nasal polyps
Submission is based on data from the pivotal SYNAPSE study
Read More
Roche’s Xolair gets US nod for nasal polyps treatment
IgE blocker approved as an add-on treatment for adult patients
Read More
AZ Fasenra shows benefit in chronic rhinosinusitis with nasal polyps
The drug reduced the size of nasal polyps and reduced nasal blockage
Read More
GSK’s Nucala shows promise in nasal polyps
Nucala is the first anti-IL5 biologic to report positive Phase III results in patients with the condition says GSK
Read More
GSK tests mepolizumab for nasal polyps
GlaxoSmithKline has kicked off a Phase III study exploring the potential of its biologic mepolizumab in patients with severe bilateral nasal polyps, a chronic inflammatory disease of the nasal passage linings or sinuses causing soft tissue growth in the upper nasal cavity.
Read More
AZ sells nasal spray rights to J&J
AstraZeneca is divesting certain rights to its nasal inflammation spray Rhincort Aqua to Johnson & Johnson group Cilag GmbH International.
Read More
- Laigo Bio completes final close of €17m seed financing round
- Axplora announces expansion as newest part of $60m API investment programme
- DNA Script signs SYNTAX distribution agreements with Gencell, BMS and Biostream
- Ondine’s Steriwave phase 3 trial reaches 93% enrolment milestone
- Arvinas reports strong phase 1 results for ARV-102 in Parkinson’s disease
